Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +32.72%
#3 Fabric Protocol Fabric Protocol +23.80%
#4 Cysic Cysic +20.00%
#5 Nockchain Nockchain +19.55%
#6 Bedrock Bedrock +17.90%
#7 Epic Chain Epic Chain +12.10%
#8 Perle Perle +11.39%
#9 FOLKS FOLKS +8.38%
#10 The Black Bull The Black Bull +8.04%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Kedudukan dalam Saham #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Harga Saham
$0.1
Disegerakkan terakhir: 2024-06-18
Modal Pasaran
$1.31M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Pascal Biosciences Inc. (PSCBF)

Kategori

Healthcare
Nisbah P/E bagi Pascal Biosciences Inc. (PSCBF)
Nisbah P/E pada August 2026 TTM: -9.02
Menurut laporan kewangan dan harga saham terkini Pascal Biosciences Inc., nisbah P/E semasa (TTM) ialah -9.02. Pada akhir 2022, syarikat mempunyai nisbah P/E sebanyak -2.82.
Sejarah nisbah P/E bagi Pascal Biosciences Inc. dari 2019 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -9.02 125.44%
2023 -4.00 42.00%
2022 -2.82 33,029.41%
2021 -0.01 8,400.00%
2020 0.00 0.00%
2019 0.00 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 28.05 -411.04%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -439.55%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 19.30 -314.01%
BE
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.